Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denis Wahl

Showing results (41-50 of 137) with videos related to

Pageof 14
Sort By:
Thrombosis and Haemostasis|February 8, 2003
Thrombinography shows acquired resistance to activated protein C in patients with lupus anticoagulantsVéronique Regnault, Suzette Béguin, Denis Wahl, et al.
Haematologica|May 10, 2007
Hypercoagulability resulting from opposite effects of lupus anticoagulants is associated strongly with thrombotic riskThomas Lecompte, Denis Wahl, Christine Perret-Guillaume, et al.
Thrombosis Research|May 17, 2013
Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort studyStéphane Zuily, Véronique Regnault, Francis Guillemin, et al.
Nephrologie & Therapeutique|October 12, 2013
[Antiphospholipid syndrome in nephrology. Kidney damage and practical aspects of the management]Manon Dekeyser, Stéphane Zuily, Jacqueline Champigneulle, et al.
Thrombosis Research|October 5, 2010
Calibrated automated thrombography demonstrates hypercoagulability in patients with idiopathic pulmonary arterial hypertensionAgnès Tournier, Denis Wahl, Ari Chaouat, et al.
Autoimmunity Reviews|January 15, 2014
Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysisQuitterie Reynaud, Jean-Christophe Lega, Patrick Mismetti, et al.
Lupus|July 21, 2021
Ophthalmologic manifestations in patients with antiphospholipid antibodies: Beware of iatrogenic complicationsJustine Menet, Nelly Agrinier, Virginie Dufrost, et al.
Haematologica|March 7, 2008
The effect of platelet activation on the hypercoagulability induced by murine monoclonal antiphospholipid antibodiesAurelie Membre, Denis Wahl, Veronique Latger-Cannard, et al.
British Journal of Haematology|July 20, 2004
Phenotypic sensitivity to activated protein C in healthy families: importance of genetic components and environmental factorsClaudia Taralunga, René Gueguen, Sophie Visvikis, et al.
Current Rheumatology Reports|February 12, 2019
Brief Report on the 11th Meeting of the European Forum on Antiphospholipid AntibodiesWalid Chayouâ, Dongmei Yin, Philip G de Groot, et al.
Pageof 14

Showing results (41-50 of 137) with videos related to

Sort By:
Pageof 14
Thrombosis and Haemostasis|February 8, 2003
Thrombinography shows acquired resistance to activated protein C in patients with lupus anticoagulantsVéronique Regnault, Suzette Béguin, Denis Wahl, et al.
Haematologica|May 10, 2007
Hypercoagulability resulting from opposite effects of lupus anticoagulants is associated strongly with thrombotic riskThomas Lecompte, Denis Wahl, Christine Perret-Guillaume, et al.
Thrombosis Research|May 17, 2013
Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort studyStéphane Zuily, Véronique Regnault, Francis Guillemin, et al.
Nephrologie & Therapeutique|October 12, 2013
[Antiphospholipid syndrome in nephrology. Kidney damage and practical aspects of the management]Manon Dekeyser, Stéphane Zuily, Jacqueline Champigneulle, et al.
Thrombosis Research|October 5, 2010
Calibrated automated thrombography demonstrates hypercoagulability in patients with idiopathic pulmonary arterial hypertensionAgnès Tournier, Denis Wahl, Ari Chaouat, et al.
Autoimmunity Reviews|January 15, 2014
Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysisQuitterie Reynaud, Jean-Christophe Lega, Patrick Mismetti, et al.
Lupus|July 21, 2021
Ophthalmologic manifestations in patients with antiphospholipid antibodies: Beware of iatrogenic complicationsJustine Menet, Nelly Agrinier, Virginie Dufrost, et al.
Haematologica|March 7, 2008
The effect of platelet activation on the hypercoagulability induced by murine monoclonal antiphospholipid antibodiesAurelie Membre, Denis Wahl, Veronique Latger-Cannard, et al.
British Journal of Haematology|July 20, 2004
Phenotypic sensitivity to activated protein C in healthy families: importance of genetic components and environmental factorsClaudia Taralunga, René Gueguen, Sophie Visvikis, et al.
Current Rheumatology Reports|February 12, 2019
Brief Report on the 11th Meeting of the European Forum on Antiphospholipid AntibodiesWalid Chayouâ, Dongmei Yin, Philip G de Groot, et al.
Pageof 14